ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 3 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,194 | -70.6% | 155,300 | -58.3% | 0.00% | -50.0% |
| Q2 2023 | $517,775 | +2.5% | 372,500 | +17.3% | 0.00% | 0.0% |
| Q1 2023 | $504,984 | -74.7% | 317,600 | -0.8% | 0.00% | -60.0% |
| Q4 2022 | $1,994,846 | +670.2% | 320,200 | +729.5% | 0.01% | +400.0% |
| Q3 2022 | $259,000 | +21.6% | 38,600 | +15.2% | 0.00% | – |
| Q2 2022 | $213,000 | +71.8% | 33,500 | +25.5% | 0.00% | – |
| Q1 2022 | $124,000 | -66.0% | 26,700 | -63.4% | 0.00% | – |
| Q4 2021 | $365,000 | +83.4% | 73,000 | +342.4% | 0.00% | – |
| Q3 2021 | $199,000 | -10.4% | 16,500 | +57.1% | 0.00% | – |
| Q2 2021 | $222,000 | +9.9% | 10,500 | +45.8% | 0.00% | – |
| Q1 2021 | $202,000 | +36.5% | 7,200 | +26.3% | 0.00% | – |
| Q4 2020 | $148,000 | -64.4% | 5,700 | -49.1% | 0.00% | -100.0% |
| Q3 2020 | $416,000 | -58.2% | 11,200 | -42.3% | 0.00% | -80.0% |
| Q2 2020 | $995,000 | +113.1% | 19,400 | +31.1% | 0.01% | +25.0% |
| Q1 2020 | $467,000 | -29.5% | 14,800 | +33.3% | 0.00% | -20.0% |
| Q4 2019 | $662,000 | +181.7% | 11,100 | +73.4% | 0.01% | +150.0% |
| Q3 2019 | $235,000 | -62.0% | 6,400 | -51.9% | 0.00% | -66.7% |
| Q2 2019 | $619,000 | -57.6% | 13,300 | -63.5% | 0.01% | -62.5% |
| Q1 2019 | $1,461,000 | -71.6% | 36,400 | -67.4% | 0.02% | -64.4% |
| Q4 2018 | $5,138,000 | -14.6% | 111,700 | -17.6% | 0.04% | -6.2% |
| Q3 2018 | $6,017,000 | -3.9% | 135,600 | -15.1% | 0.05% | -11.1% |
| Q2 2018 | $6,263,000 | +128.5% | 159,800 | +321.6% | 0.05% | +92.9% |
| Q1 2018 | $2,741,000 | +402.0% | 37,900 | +356.6% | 0.03% | +600.0% |
| Q4 2017 | $546,000 | -79.1% | 8,300 | -84.1% | 0.00% | -83.3% |
| Q3 2017 | $2,611,000 | -60.8% | 52,100 | -63.8% | 0.02% | -65.2% |
| Q2 2017 | $6,664,000 | -52.4% | 144,000 | -63.7% | 0.07% | -57.7% |
| Q1 2017 | $13,997,000 | +466466.7% | 396,400 | +198100.0% | 0.16% | – |
| Q3 2016 | $3,000 | +200.0% | 200 | +100.0% | 0.00% | – |
| Q2 2016 | $1,000 | -98.8% | 100 | -98.0% | 0.00% | -100.0% |
| Q1 2016 | $86,000 | +177.4% | 5,100 | +264.3% | 0.00% | – |
| Q4 2015 | $31,000 | -96.4% | 1,400 | -96.2% | 0.00% | -100.0% |
| Q3 2015 | $863,000 | -56.0% | 36,600 | +52.5% | 0.01% | -55.6% |
| Q2 2015 | $1,962,000 | -12.1% | 24,000 | -0.4% | 0.03% | -22.9% |
| Q1 2015 | $2,232,000 | +314.9% | 24,100 | +81.2% | 0.04% | +337.5% |
| Q4 2014 | $538,000 | – | 13,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 11,200 | $416,000 | 0.00% |
| SIMPLEX TRADING, LLC | 156 | $579,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 300 | $11,000 | 0.00% |